Preferred Name |
tocilizumab |
|
Synonyms |
BAT-1806 |
|
ID |
http://purl.bioontology.org/ontology/MESH/C502936 |
|
altLabel |
BAT-1806 atlizumab MSB-11456 RO-4877533 R-1569 Roactemra monoclonal antibody, MRA BAT1806 RHPM-1 Actemra MSB11456 RG-1569 |
|
cui |
C5564824 C5226663 C5227772 C3272237 C1609165 C2830231 C5227770 C2740854 |
|
HM |
D061067 |
|
Inverse of RB |
I031V2H011 0 |
|
LT |
TRD |
|
Mapped to | ||
MDA |
20050818 |
|
MeSH Frequency |
3145 |
|
MMR |
20220214 |
|
notation |
C502936 |
|
PI |
*ANTIBODIES, MONOCLONAL (2005-2011) |
|
prefLabel |
tocilizumab |
|
SC |
1 |
|
Scope Statement |
a humanised anti-interleukin-6 receptor monoclonal antibody |
|
SRC |
Nippon Rinsho 2005 May;63 Suppl 5:723-7 |
|
TERMUI |
T575947 T001116066 T001092459 T000967532 T794499 T001116065 T000967526 T549198 T648929 T000967534 T000967527 T000967533 T000967531 |
|
TH |
NLM (2004) NLM (2005) NLM (2020) FDA SRS (2017) NLM (2012) NLM (2022) USAN (19XX) INN (19XX) NLM (2003) |
|
tui |
T116 T129 T121 |
Create mapping